Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Efficacy of Kan Jang® in Patients with Mild COVID-19: Interim Analysis of a Randomized, Quadruple-Blind, Placebo-Controlled Trial. | Pharmaceuticals (Basel) | 2022 | 36015163 | PubTator, text mining | PubMed |
| Recent Developments in the Understanding of Immunity, Pathogenesis and Management of COVID-19. | Int J Mol Sci | 2022 | 36012562 | PubTator, text mining | PubMed |
| SARS-CoV-2 genome variations and evolution patterns in Egypt: a multi-center study. | Sci Rep | 2022 | 36008511 | PubTator, text mining | PubMed |
| Characterization of a cluster of COVID-19 cases linked to the Omicron variant, in Mauritania. | Tunis Med | 2022 | 36005913 | PubTator, text mining | PubMed |
| A computational approach to rapidly design peptides that detect SARS-CoV-2 surface protein S. | NAR Genom Bioinform | 2022 | 36004308 | PubTator, text mining | PubMed |
| Roles and functions of SARS-CoV-2 proteins in host immune evasion. | Front Immunol | 2022 | 36003396 | PubTator, text mining | PubMed |
| Epigenetic perspectives of COVID-19: Virus infection to disease progression and therapeutic control. | Biochim Biophys Acta Mol Basis Dis | 2022 | 36002132 | PubTator, text mining | PubMed |
| Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine. | Int Immunopharmacol | 2022 | 35998506 | PubTator, text mining | PubMed |
| Human coronaviruses disassemble processing bodies. | PLoS Pathog | 2022 | 35998203 | PubTator, text mining | PubMed |
| Plant-derived compounds effectively inhibit the main protease of SARS-CoV-2: An in silico approach. | PLoS One | 2022 | 35998194 | PubTator, text mining | PubMed |
| Synthetically recoded virus sCPD9 - A tool to accelerate SARS-CoV-2 research under biosafety level 2 conditions. | Comput Struct Biotechnol J | 2022 | 35992535 | PubTator, text mining | PubMed |
| A comprehensive analysis of the mutational landscape of the newly emerging Omicron (B.1.1.529) variant and comparison of mutations with VOCs and VOIs. | Geroscience | 2022 | 35989365 | PubTator, text mining | PubMed |
| Punicalagin as an allosteric NSP13 helicase inhibitor potently suppresses SARS-CoV-2 replication in vitro. | Antiviral Res | 2022 | 35985407 | PubTator, text mining | PubMed |
| Digging for the discovery of SARS-CoV-2 nsp12 inhibitors: a pharmacophore-based and molecular dynamics simulation study. | Future Virol | 2022 | 35983350 | PubTator, text mining | PubMed |
| Quercetin, a flavonoid, combats rotavirus infection by deactivating rotavirus-induced pro-survival NF-κB pathway. | Front Microbiol | 2022 | 35983320 | PubTator, text mining | PubMed |
| Development and application of ribonucleic acid therapy strategies against COVID-19. | Int J Biol Sci | 2022 | 35982905 | PubTator, text mining | PubMed |
| Genomics and pathogenesis of the avian coronavirus infectious bronchitis virus. | Aust Vet J | 2022 | 35978541 | PubTator, text mining | PubMed |
| A fuzzy logic-based computational method for the repurposing of drugs against COVID-19. | Bioimpacts | 2022 | 35975205 | PubTator, text mining | PubMed |
| Discovery of novel druggable pockets on polyomavirus VP1 through crystallographic fragment-based screening to develop capsid assembly inhibitors. | RSC Chem Biol | 2022 | 35974998 | PubTator, text mining | PubMed |
| Sewage surveillance of SARS-CoV-2 at student campus residences in the Western Cape, South Africa. | Sci Total Environ | 2022 | 35973539 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=42